The National Institute of Mental Health (NIMH) is rolling out new rules for clinical trials testing psychiatric drugs or interventions. For years, applications have proposed testing to see if Drug X helps with a particular condition, like depression, schizophrenia, anorexia etc.
If a drug does show an effect on the particular condition being tested, we have learned that we may have a new treatment for that condition. “Hooray!” If a drug does not show an effect on the particular condition being tested, we have learned that we may not have a new treatment for that condition, which is pretty much what we knew before the expensive clinical trial.
The NIMH has created new funding rules in an attempt to address this issue. Continue reading “Better Trials, So Failure Isn’t All Bad”